((Bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists

Details for Australian Patent Application No. 2008256926 (hide)

Owner Allergan, Inc.

Inventors Heidelbaugh, Todd M.; Bhat, Smita S.; Chow, Ken; Nguyen, Phong X.; Garst, Michael E.; Sinha, Santosh C.

Agent Davies Collison Cave

Pub. Number AU-A-2008256926

PCT Pub. Number WO2008/147786

Priority 60/939,781 23.05.07 US

Filing date 21 May 2008

Wipo publication date 4 December 2008

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/147786 Priority application(s): WO2008/147786

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008256928-Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds

2008256922-Raf inhibitors for the treatment of thyroid cancer